One Family’s Battle With Early-Onset Dementia Could Offer Clues to Future Treatments

A family’s decades-long struggle with early-onset dementia is giving researchers a rare window into how genetic mutations can trigger devastating changes in the brain — and why studying these uncommon diseases could eventually help advance treatments for more common forms of dementia.

The family’s story is chronicled in journalist Robert Kolker’s new book, The Vanishing Family: Love, Fate and the Quest to End Dementia. The book follows three generations affected by a rare inherited form of frontotemporal dementia, or FTD, while examining how scientists’ understanding of dementia has changed over generations.

The story is particularly notable because some members of the family developed serious cognitive and behavioral changes while still relatively young.

A pattern of dementia emerged in midlife

The family’s experience began with Jean, a woman who developed significant changes in her 50s. According to the account described in Kolker’s book, she became increasingly withdrawn and eventually died at 62 after battling breast cancer.

Initially, her children believed lifestyle factors might have contributed to what they had witnessed.

Years later, however, similar changes appeared in another member of the family.

Christy, a successful executive and mother of two, began experiencing dramatic behavioral changes at age 44. She stopped properly caring for herself, struggled professionally and behaved differently in social situations.

Doctors eventually diagnosed her with Pick’s disease, an older term associated with a form of frontotemporal dementia that can occur before age 65.

The similarities between Christy and her mother prompted other members of the family to investigate whether genetics could be involved.

Scientists eventually identified a genetic mutation

In 2001, family members contacted researchers who were investigating genetic links to dementia. Several relatives provided DNA samples in an effort to determine whether an inherited mutation might explain the pattern.

The answer did not come immediately.

Several years later, another sister, Mary, began showing unusual behavioral and communication changes. Her visit to the family convinced Barb, another sister whose story anchors Kolker’s book, that the family might be facing a hereditary neurological disorder.

Further investigation eventually identified a mutation known as V337M on chromosome 17. The mutation is associated with an inherited form of frontotemporal dementia involving abnormal tau proteins.

For families carrying the mutation, the genetic stakes are substantial: children of an affected carrier have a 50% chance of inheriting the mutation.

That discovery also created a difficult personal question for relatives: whether to undergo genetic testing and learn whether they carried a mutation associated with dementia later in life.

Why frontotemporal dementia matters to Alzheimer’s research

Frontotemporal dementia is different from typical late-onset Alzheimer’s disease, but researchers increasingly see value in studying rare forms of dementia because they can reveal specific biological mechanisms behind brain degeneration.

FTD often affects behavior, personality, language and executive abilities, sometimes years or decades before the age at which Alzheimer’s disease typically appears.

In the family described by Kolker, the V337M mutation affects tau, a protein that normally performs important functions inside nerve cells. Abnormal tau can contribute to the degeneration of brain cells and the symptoms associated with certain forms of dementia.

That makes the family scientifically important beyond its own experience.

Researchers studying an inherited mutation have something that can be difficult to find in more common forms of dementia: a relatively clear genetic starting point.

Understanding what happens after that mutation occurs could help scientists identify biological pathways that might also be involved in other neurodegenerative diseases.

The changing science of dementia

For much of medical history, dementia was viewed broadly as a consequence of aging.

That understanding changed significantly in the early 20th century after scientists identified characteristic abnormalities in the brains of people with what became known as Alzheimer’s disease.

Research subsequently focused heavily on amyloid plaques, abnormal deposits associated with Alzheimer’s. The amyloid cascade hypothesis became one of the dominant explanations for how Alzheimer’s develops.

But decades of research and unsuccessful or limited treatments have encouraged scientists to investigate additional mechanisms, including tau pathology and other biological processes.

The story of the family in The Vanishing Family illustrates how rare inherited disorders can challenge assumptions and point researchers toward different mechanisms of neurological disease.

Could genetic research lead to new dementia treatments?

Researchers are now investigating several approaches that could eventually target the underlying causes of inherited forms of dementia.

Among them are therapies designed to target abnormal tau proteins. Other research is exploring gene therapy and gene-editing technologies that could potentially address specific disease-causing mutations.

These approaches remain experimental and should not be interpreted as established cures.

The scientific importance of the family is instead that it provides researchers with an opportunity to study a clearly identifiable genetic mutation and follow its effects on the brain.

The hope is that understanding such mechanisms could eventually contribute to treatments not only for rare inherited dementias but also for more widespread neurological diseases.

Why genetic testing and research participation matter

One of the central themes of the family’s story is the importance of identifying people affected by rare forms of dementia.

Because FTD is less common than Alzheimer’s disease, some cases can be difficult to recognize or diagnose. The New York Post report notes that the estimated number of FTD cases in the United States may be significantly underestimated.

Greater awareness and accurate diagnosis could help researchers recruit participants for clinical studies and better understand how different genetic mutations affect the brain.

For families with a history of unusually early dementia, genetic counseling can also help people understand whether testing may be appropriate and what the results could mean.

Genetic testing is a personal medical decision, however, and should generally be discussed with qualified healthcare professionals and genetic counselors.

A family story with implications for dementia research

The story documented in The Vanishing Family is ultimately about more than one family’s experience.

It demonstrates how an unusual pattern of illness can lead researchers toward questions that might otherwise remain hidden. A rare mutation affecting one family can provide a natural experiment for understanding biological processes that may also be relevant to other neurodegenerative diseases.

The research does not yet provide a cure for inherited FTD or Alzheimer’s disease. But scientists are increasingly investigating tau-targeting drugs, genetic approaches and other strategies that could eventually change how some dementias are treated.

For the family at the center of Kolker’s book, years of uncertainty and loss have become part of a much larger scientific story — one in which understanding a rare form of dementia could potentially help researchers uncover new ways to fight brain degeneration.

Source: New York Post, September 27, 2026.